Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

748.64 +0.63 (+0.08%)
Streaming Delayed Price Updated: 1:27 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
99 100 Next >
Stock Split Watch: Is Eli Lilly Next?
Eli Lilly's revenue has climbed, thanks to high demand for its weight loss drugs. 
Via The Motley Fool
AI Play Arista Networks At All-Time High, Leads List Of Newcomers To IBD Top Stock Lists Like IBD 50, Other Premium Lists
Arista Networks' EPS growth ranged up to 49% over the past four quarters. It was among nine stocks added to IBD top stock lists Thursday. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions. 
Via InvestorPlace
Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand
Novo Nordisk will limit initial sales of Wegovy in China to manage global supply and address the rising obesity rates in the world's most populous country. The competitive landscape and regulatory... 
Via Benzinga
3 Promising Stocks That Can Turn $10K Into $1 Million
$10,000 dollars invested in these high-growth stocks can legitimately grow into one million with shorter timelines than expected overall. 
Via InvestorPlace
Chart Of The Day: Eli Lilly - More New Highs
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. 
Via Talk Markets
This Is What Whales Are Betting On Eli Lilly and Co
Via Benzinga
7 A-Rated Stocks for Your June Buy List
While there's no bad time to buy A-rated stocks, these equities represent companies that are must-own picks for June 2024. 
Via InvestorPlace
3 Valuable Stocks That Are Worth the Expensive Price Tag
Putting your hard-earned money into the stock market? Here are expensive stocks worth buying for the long-term. 
Via InvestorPlace
Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Active Fund Managers Bet These 6 Stocks Will Trade Near All-Time Highs
Active fund managers making large bets on momentum plays indicate confidence that Big Tech's rally has legs for the remainder of 2024. 
Via Benzinga
The Next 7 Trillion-Dollar Stocks to Buy: June 2024 Edition
The next trillion dollar stocks have emerged in a few key areas that investors should understand in greater detail in order to profit. 
Via InvestorPlace
Better Growth Stock: Archer Aviation or Viking Therapeutics?
Which one of these potential disruptors is the better buy? 
Via The Motley Fool
2 Reasons Why Eli Lilly's Stock Likely Hasn't Peaked
The stock may seem expensive right now, but that may not be the case in a few years. 
Via The Motley Fool
Alphabet Among Stocks Hitting All-Time High Tuesday: See Which Stocks Just Came On IBD's Top Stock Screens
Google-parent Alphabet hit a fresh high at 184.03 Tuesday. Its earnings rose the past year to a 53% surge to $1.74 per share last quarter. 
Via Investor's Business Daily
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
Novo Nordisk's Saxenda study published in JAMA Network Open reveals significant declines in bone density among patients, raising concerns for similar weight loss drugs. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
Eli Lilly collaborates with Microsoft-backed OpenAI to leverage generative AI for developing novel antimicrobials targeting drug-resistant pathogens. This partnership supports Lilly's commitment to... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug
Novo Nordisk and Eli Lilly dominate the market for GLP-1 drugs, and are racing ahead to produce more of them. 
Via InvestorPlace
1 Supercharged Vanguard Index Fund to Buy Before It Soars 174%, According to a Wall Street Analyst
The Vanguard S&P 500 ETF includes many of the most influential stocks in the world, such as Microsoft, Apple, Nvidia, Alphabet, and Amazon. 
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
What's Going On With Eli Lilly Shares Monday?
Eli Lilly and Co (NYSE: LLY) shares are moving higher Monday following the release of positive Phase 3 trial results for its weight loss drug, tirzepatide, marketed as Zepbound. 
Via Benzinga
Why ResMed Shares Are Trading Lower Monday
ResMed stock is trading lower Monday after Eli Lilly and Company released data from a clinical trial in regards to the treatment of sleep apnea. 
Via Benzinga
Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely'
Eli Lilly's stock may rise due to supply issues at competitor Novo Nordisk, according to Reddit users. Its weight loss drug and upcoming FDA approval are also factors. Investors are optimistic about... 
Via Benzinga
Exposures Product Safety
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Top 3 Sectors Poised For Growth This Summer
Communications, technology, and healthcare are the three hottest sectors for growth, but not all stocks will rise with the tides. 
Via MarketBeat
Topics ETFs
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today. 
Via InvestorPlace
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
Eli Lilly tested its weight-loss drug in people with obesity suffering from sleep apnea events. 
Via Investor's Business Daily
Eli Lilly's Zepbound For Weight Loss Shows Disease Resolution In Obese Sleep Apnea Patients, Lays Further Groundwork For Label Expansion
Eli Lilly's phase 3 SURMOUNT-OSA trials show tirzepatide injection significantly reduces apnea events in adults with obesity and moderate-to-severe obstructive sleep apnea. FDA decision expected by end... 
Via Benzinga
Exposures Product Safety
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
Here are some highlights from a detailed, quantitative analysis AbbVie Inc. stock. Let's take a closer look at various factors, such as the stock's value and dividend. 
Via Talk Markets
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.